CELLDEX THERAPEUTICS: BARZOLVOLIMAB WELL TOLERATED; LOADING DOSE FOLLOWED BY Q4W DOSING SHOW FAVORABLE SAFETY PROFILE CONSISTENT WITH PRIOR STUDIES

Reuters · 3d ago

Please log in to view news